Washington § 74.09.559 Long-acting injectable buprenorphine—Billing codes—Reimbursement.

Washington Statutes

§ 74.09.559 — Long-acting injectable buprenorphine—Billing codes—Reimbursement.

Washington § 74.09.559

Title 74PUBLIC ASSISTANCE

Ch. 74.09MEDICAL CARE

This text of Washington § 74.09.559 (Long-acting injectable buprenorphine—Billing codes—Reimbursement.) is published on Counsel Stack Legal Research, covering Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Wash. Rev. Code § 74.09.559 (2026).

Text

(1)The authority shall establish appropriate billing codes for hospitals and psychiatric hospitals that administer long-acting injectable buprenorphine on an outpatient basis to use for billing patients enrolled in a medical assistance program.

(2)Upon initiation or renewal of a contract with the authority to administer a medicaid managed care plan, a managed care organization must reimburse a hospital or psychiatric hospital that bills for the administration of long-acting injectable buprenorphine on an outpatient basis as a separate reimbursable expense.

(3)Beginning January 1, 2025, for individuals enrolled in a medical assistance program that is not a medicaid managed care plan, the authority must reimburse a hospital or psychiatric hospital that bills for the administration of lo

Free access — add to your briefcase to read the full text and ask questions with AI

(1) The authority shall establish appropriate billing codes for hospitals and psychiatric hospitals that administer long-acting injectable buprenorphine on an outpatient basis to use for billing patients enrolled in a medical assistance program.

(2) Upon initiation or renewal of a contract with the authority to administer a medicaid managed care plan, a managed care organization must reimburse a hospital or psychiatric hospital that bills for the administration of long-acting injectable buprenorphine on an outpatient basis as a separate reimbursable expense.

(3) Beginning January 1, 2025, for individuals enrolled in a medical assistance program that is not a medicaid managed care plan, the authority must reimburse a hospital or psychiatric hospital that bills for the administration of long-acting injectable buprenorphine on an outpatient basis administered as a separate reimbursable expense.

(4) Reimbursements provided under this section must be separate from any bundled payment for outpatient hospital or emergency department services.

Findings — Intent — 2024 c 366: See note following RCW 71.24.847 .